← Open Payments lookup

KELLIE GUARINO: Open Payments

NPI 1679274138 · MARLTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,066 in 63 payments from 11 companies in 2025. Trend: 2023 $570 · 2024 $1,089 · 2025 $1,066

Food & beverage: $955Education: $111
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.12$266
Neurocrine BioSciences, Inc.18$251
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)11$162
E.R. Squibb & Sons, L.L.C.5$89
Vanda Pharmaceuticals Inc.5$87
Otsuka America Pharmaceutical, Inc.5$86
Alkermes, Inc.2$39
Janssen Pharmaceuticals, Inc2$31
ABBVIE INC.1$19
Lundbeck LLC1$18

Products named: INGREZZA, CAPLYTA, AUSTEDO XR, REXULTI, COBENFY, FANAPT, LYBALVI, INVEGA.

Industry payments across NJ — which companies pay providers there.